127 related articles for article (PubMed ID: 33991632)
21. Synthesis and antioxidant activities of acetamidomethylsulfonyl bis heterocycles-oxazolyl/thiazolyl/imidazolyl-1,3,4-oxadiazoles.
Mahaboob Basha N; Lavanya G; Padmaja A; Padmavathi V
Arch Pharm (Weinheim); 2013 Jul; 346(7):511-20. PubMed ID: 23801190
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of new 2,5-di-substituted 1,3,4-oxadiazoles bearing 2,6-di-tert-butylphenol moieties and evaluation of their antioxidant activity.
Shakir RM; Ariffin A; Abdulla MA
Molecules; 2014 Mar; 19(3):3436-49. PubMed ID: 24658568
[TBL] [Abstract][Full Text] [Related]
23. New 1,3,4-Oxadiazole Derivatives of Pyridothiazine-1,1-Dioxide with Anti-Inflammatory Activity.
Glomb T; Wiatrak B; Gębczak K; Gębarowski T; Bodetko D; Czyżnikowska Ż; Świątek P
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266208
[TBL] [Abstract][Full Text] [Related]
24. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant and antitumor activities of new synthesized aromatic C-nucleoside derivatives.
El Sadek MM; Abd El-Dayem NS; Hassan SY; Mostafa MA; Yacout GA
Molecules; 2014 Apr; 19(4):5163-90. PubMed ID: 24759075
[TBL] [Abstract][Full Text] [Related]
26. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.
Rayar AM; Lagarde N; Martin F; Blanchard F; Liagre B; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitía M
Eur J Med Chem; 2018 Feb; 146():577-587. PubMed ID: 29407982
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of in vitro antioxidant properties of novel 2,5-disubstituted 1,3,4-oxadiazoles.
Lakshmi Ranganatha V; Khanum SA
Bioorg Khim; 2014; 40(2):226-33. PubMed ID: 25895343
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
[TBL] [Abstract][Full Text] [Related]
31. Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies.
Youssif BGM; Mohamed MFA; Al-Sanea MM; Moustafa AH; Abdelhamid AA; Gomaa HAM
Bioorg Chem; 2019 Apr; 85():577-584. PubMed ID: 30878890
[TBL] [Abstract][Full Text] [Related]
32. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-
Peregrym K; Szczukowski Ł; Wiatrak B; Potyrak K; Czyżnikowska Ż; Świątek P
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502040
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
[TBL] [Abstract][Full Text] [Related]
34. New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition.
Abdelgawad MA; Bakr RB; Ahmad W; Al-Sanea MM; Elshemy HAH
Bioorg Chem; 2019 Nov; 92():103218. PubMed ID: 31536956
[TBL] [Abstract][Full Text] [Related]
35. Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors.
Scholz M; Blobaum AL; Marnett LJ; Hey-Hawkins E
Bioorg Med Chem; 2012 Aug; 20(15):4830-7. PubMed ID: 22748709
[TBL] [Abstract][Full Text] [Related]
36. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of tetrazole derivatives as TNF-α, IL-6 and COX-2 inhibitors with antimicrobial activity: Computational analysis, molecular modeling study and region-specific cyclization using 2D NMR tools.
Lamie PF; Azmey AF
Bioorg Chem; 2019 Nov; 92():103301. PubMed ID: 31563696
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies.
Alfayomy AM; Abdel-Aziz SA; Marzouk AA; Shaykoon MSA; Narumi A; Konno H; Abou-Seri SM; Ragab FAF
Bioorg Chem; 2021 Mar; 108():104555. PubMed ID: 33376011
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and amelioration of inflammatory paw edema by novel benzophenone appended oxadiazole derivatives by exhibiting cyclooxygenase-2 antagonist activity.
Puttaswamy N; Malojiao VH; Mohammed YHE; Sherapura A; Prabhakar BT; Khanum SA
Biomed Pharmacother; 2018 Jul; 103():1446-1455. PubMed ID: 29864929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
